215 related articles for article (PubMed ID: 25612652)
1. Thyroid cytopathology with an emphasis on the 'atypical cells of uncertain significance' category: a 3-year audit with cytohistologic correlation.
Fatman L; Michelow P
Acta Cytol; 2015; 59(1):17-25. PubMed ID: 25612652
[TBL] [Abstract][Full Text] [Related]
2. Risk of Malignancy and Risk of Neoplasia in the Bethesda Indeterminate Categories: Study on 4,532 Thyroid Fine-Needle Aspirations from a Single Institution in India.
Mahajan S; Srinivasan R; Rajwanshi A; Radotra B; Panda N; Dey P; Gupta N; Nijhawan R
Acta Cytol; 2017; 61(2):103-110. PubMed ID: 28407624
[TBL] [Abstract][Full Text] [Related]
3. The prediction of malignant risk in the category "atypia of undetermined significance/follicular lesion of undetermined significance" of the Bethesda System for Reporting Thyroid Cytopathology using subcategorization and BRAF mutation results.
Hyeon J; Ahn S; Shin JH; Oh YL
Cancer Cytopathol; 2014 May; 122(5):368-76. PubMed ID: 24591408
[TBL] [Abstract][Full Text] [Related]
4. Reproducibility of atypia of undetermined significance/follicular lesion of undetermined significance category using the bethesda system for reporting thyroid cytology when reviewing slides from different institutions: A study of interobserver variability among cytopathologists.
Padmanabhan V; Marshall CB; Akdas Barkan G; Ghofrani M; Laser A; Tolgay Ocal I; David Sturgis C; Souers R; Kurtycz DF
Diagn Cytopathol; 2017 May; 45(5):399-405. PubMed ID: 28217980
[TBL] [Abstract][Full Text] [Related]
5. Risk of malignancy according to sub-classification of the atypia of undetermined significance or follicular lesion of undetermined significance (AUS/FLUS) category in the Bethesda system for reporting thyroid cytopathology.
Kim SJ; Roh J; Baek JH; Hong SJ; Shong YK; Kim WB; Song DE
Cytopathology; 2017 Feb; 28(1):65-73. PubMed ID: 27245883
[TBL] [Abstract][Full Text] [Related]
6. Thyroid atypia of undetermined significance or follicular lesion of undetermined significance: an indispensable Bethesda 2010 diagnostic category or waste garbage?
Kholová I; Ludvíková M
Acta Cytol; 2014; 58(4):319-29. PubMed ID: 25195864
[TBL] [Abstract][Full Text] [Related]
7. A meta-analytic review of the Bethesda System for Reporting Thyroid Cytopathology: Has the rate of malignancy in indeterminate lesions been underestimated?
Straccia P; Rossi ED; Bizzarro T; Brunelli C; Cianfrini F; Damiani D; Fadda G
Cancer Cytopathol; 2015 Dec; 123(12):713-22. PubMed ID: 26355876
[TBL] [Abstract][Full Text] [Related]
8. The impact of atypia/follicular lesion of undetermined significance and repeat fine-needle aspiration: 5 years before and after implementation of the Bethesda System.
Sullivan PS; Hirschowitz SL; Fung PC; Apple SK
Cancer Cytopathol; 2014 Dec; 122(12):866-72. PubMed ID: 25078420
[TBL] [Abstract][Full Text] [Related]
9. A study of malignancy rates in different diagnostic categories of the Bethesda system for reporting thyroid cytopathology: An institutional experience.
Arul P; Akshatha C; Masilamani S
Biomed J; 2015 Dec; 38(6):517-22. PubMed ID: 27013451
[TBL] [Abstract][Full Text] [Related]
10. The impact of atypia/follicular lesion of undetermined significance on the rate of malignancy in thyroid fine-needle aspiration: evaluation of the Bethesda System for Reporting Thyroid Cytopathology.
Broome JT; Solorzano CC
Surgery; 2011 Dec; 150(6):1234-41. PubMed ID: 22136846
[TBL] [Abstract][Full Text] [Related]
11. Subcategorisation of AUS/FLUS thyroid lesions as per the 2017 Bethesda System for Reporting Thyroid Cytopathology: a retrospective study from a tertiary care centre analysing risk of malignancy (ROM) of the different subcategories.
Guleria P; Agarwal S; Iyer VK; Jain D; Mathur SR; Yadav D
J Clin Pathol; 2019 Nov; 72(11):771-777. PubMed ID: 31375535
[TBL] [Abstract][Full Text] [Related]
12. The Bethesda System for Reporting Thyroid Fine-Needle Aspiration Cytology: A Kuwaiti Experience - A Cytohistopathological Study of 374 Cases.
Kapila K; Qadan L; Ali RH; Jaragh M; George SS; Haji BE
Acta Cytol; 2015; 59(2):133-8. PubMed ID: 25676743
[TBL] [Abstract][Full Text] [Related]
13. The Bethesda system for reporting thyroid cytopathology: an institutional experience of the outcome of indeterminate categories.
Onder S; Firat P; Ates D
Cytopathology; 2014 Jun; 25(3):177-84. PubMed ID: 23998291
[TBL] [Abstract][Full Text] [Related]
14. Hürthle cell presence alters the distribution and outcome of categories in the Bethesda system for reporting thyroid cytopathology.
Yazgan A; Balci S; Dincer N; Kiyak G; Tuzun D; Ersoy R; Cakir B; Guler G
Cytopathology; 2014 Jun; 25(3):185-9. PubMed ID: 24024935
[TBL] [Abstract][Full Text] [Related]
15. The surgery and repeat aspiration outcomes of the atypia of undetermined significance/follicular lesion of undetermined significance category in The Bethesda System for Reporting Thyroid Cytopathology.
Jan IS; Lee YT; Wang CM; Cheng TY; Wang CY; Chang TC; Shih SR
Asian J Surg; 2019 Jan; 42(1):144-147. PubMed ID: 29653826
[TBL] [Abstract][Full Text] [Related]
16. The Bethesda terminology for reporting thyroid cytopathology: from theory to practice in Europe.
Cochand-Priollet B; Schmitt FC; Tötsch M; Vielh P;
Acta Cytol; 2011; 55(6):507-11. PubMed ID: 22156458
[TBL] [Abstract][Full Text] [Related]
17. Thyroid cytology in Pakistan: An institutional audit of the atypia of undetermined significance/follicular lesion of undetermined significance category.
Fatima S; Qureshi R; Imran S; Idrees R; Ahmad Z; Kayani N; Ahmed A
Cytopathology; 2021 Mar; 32(2):205-210. PubMed ID: 33098589
[TBL] [Abstract][Full Text] [Related]
18. Cytological Diagnosis of Follicular Variant of Papillary Thyroid Carcinoma before and after the Bethesda System for Reporting Thyroid Cytopathology.
Fazeli R; VandenBussche CJ; Bishop JA; Ali SZ
Acta Cytol; 2016; 60(1):14-8. PubMed ID: 27007511
[TBL] [Abstract][Full Text] [Related]
19. Risk of malignancy in Thyroid "Atypia of undetermined significance/Follicular lesion of undetermined significance" and its subcategories - A 5-year experience.
Thakur A; Sarin H; Kaur D; Sarin D
Indian J Pathol Microbiol; 2019; 62(4):544-548. PubMed ID: 31611437
[TBL] [Abstract][Full Text] [Related]
20. Subclassification of the Bethesda Category III (AUS/FLUS): A study of thyroid FNA cytology based on ThinPrep slides from the National Cancer Center in China.
Zhao H; Guo H; Zhao L; Cao J; Sun Y; Wang C; Zhang Z
Cancer Cytopathol; 2021 Aug; 129(8):642-648. PubMed ID: 34139103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]